Monday, 3 November 2014

Investors Watch List: ZIOPHARM Oncology (NASDAQ:ZIOP), Nokia Corporation (ADR) (NYSE:NOK), Addus HomeCare Corporation (NASDAQ:ADUS), Theravance (NASDAQ:THRX), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Investors Watch List: ZIOPHARM Oncology (NASDAQ:ZIOP), Nokia Corporation (ADR) (NYSE:NOK), Addus HomeCare Corporation (NASDAQ:ADUS), Theravance (NASDAQ:THRX), Dipexium Pharmaceuticals (NASDAQ:DPRX)
(NASDAQ:ZIOP) announced Net loss for the third quarter of 2014 was $6.1 million, or $(0.06) per share, compared to a net loss of $16.7 million, or $(0.20) per share, for the third quarter of 2013. Included in the loss for the third quarter of 2014 was a non-cash gain of $5.8 million compared to a non-cash loss of $7.4 million for the third quarter of 2013. The non-cash gain/loss is related to the change in the fair value of the company’s outstanding liability-classified warrants. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)’s stock on 31 October traded at beginning with a price of $3.16 and when day-trade ended the stock finally increased 8.50% to end at $3.32. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)’s showed weekly performance of 2.47%.
According to reports, Chennai plant of Nokia Corporation (ADR) (NYSE:NOK) India is on the verge of shutting down, but no support from the local government has been offered so far. There was a time when J Jayalalithaa, Chief Minister of Tamil Nadu was the first person to ask NOK during 2003-04 time to set up its first plant in India on Chennai soil. Things have changed now as the current ruling party All India Anna Dravida Munnetra Kazhagam has remained silent when NOK is facing troubles to continue its operations in India. Nokia Corporation (ADR) (NYSE:NOK) on Friday closed at $8.27. Stock institutional ownership is 11.50%. Nokia Corporation (ADR) (NYSE:NOK) distance from 50-day simple moving average (SMA50) is -0.30%.
Addus Homecare Corporation (NASDAQ:ADUS) announced its earningsresults on Thursday. The company reported $0.29 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.29, AnalystRatingsNetwork.com reports. Addus HomeCare Corporation (NASDAQ:ADUS)’s shares on Friday traded in the range of 19.51 – 20.45and ended up on $19.87. Addus HomeCare Corporation (NASDAQ:ADUS) distance from 200-day simple moving average (SMA200) is -11.44%. ADUS’s sales growth for past 5 years was 6.10% and its EPS growth for past 5 years was 18.90%.
Theravance Inc. (NASDAQ:THRX) declared a quarterly dividend on Friday, October 31st, Analyst Ratings.Net reports. Investors of record on Tuesday, November 25th will be given a dividend of 0.25 per share on Tuesday, December 23rd. This represents a $1.00 dividend on an annualized basis and a yield of 6.26%. The ex-dividend date of this dividend is Friday, November 21st.Theravance Inc. (NASDAQ:THRX)’s stock on 31 October decreased -1.17% to the closing price of $16.02. Its fifty two weeks range is $15.56 – 32.8928. The total market capitalization recorded $1.843B. Theravance Inc. (NASDAQ:THRX) monthly performance is -0.93%.
Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) on Friday closed at $10.95. Stock institutional ownership is 22.40% while insider ownership includes 0.60%. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) distance from 50-day simple moving average (SMA50) is 9.45%.

No comments:

Post a Comment